Finance

Beta
Lists
VXL:CVE
Vaxil Bio Ltd
CA$0.18
-7.69%
(-0.015) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for VXL...
Open
CA$0.18
High
CA$0.18
Low
CA$0.18
Mkt. cap
717.12K
Avg. vol.
335.00
Volume
6.03K
P/E ratio
1.10
52-wk high
CA$0.32
52-wk low
CA$0.13
EPS
CA$0.16
Beta
-0.68
Shares outstanding
3.98M
Open
CA$0.18
High
CA$0.18
Low
CA$0.18
Mkt. cap
717.12K
Avg. vol.
335.00
Volume
6.03K
P/E ratio
1.10
52-wk high
CA$0.32
52-wk low
CA$0.13
EPS
CA$0.16
Beta
-0.68
Shares outstanding
3.98M
News stories
From sources across the web
About Vaxil Bio Ltd
CEO-
Employees-
Founded2009
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.00K
32.00K
44.00K
109.00K
Operating expense
37.00K
32.00K
44.00K
109.00K
Total operating expenses
37.00K
32.00K
44.00K
109.00K
Operating income
-37.00K
-32.00K
-44.00K
-109.00K
Other non operating income
-
-
-
-
EBT including unusual items
36.00K
-20.00K
567.00K
-107.00K
EBT excluding unusual items
36.00K
-20.00K
-46.00K
-107.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
42.00K
-20.00K
570.00K
-107.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
73.00K
12.00K
-
2.00K
Interest expense
-
-
-2.00K
-
Net interest expenses
73.00K
12.00K
-2.00K
2.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more